Lymphocytoma cutis reflects an exaggerated local immunologic reaction to a stimulus presenting on the head, neck, or upper extremities as a firm 1-3 cm erythematous and/or violaceous plaque or nodule. However, lymphocytoma cutis may be difficult to treat due to the variety of causative agents and the lack of reported successful treatments and outcomes. Here, we present a case of 68-year-old female with recalcitrant lymphocytoma cutis resistant to other first-line therapies including tacrolimus ointment and steroids. The red plaque on the patient's left cheek was eventually treated with mycophenolate mofetil. Mycophenolate mofetil was an accessible and effective therapeutic option to treat lymphocytoma cutis with minimal side effects.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207277 | PMC |
| http://dx.doi.org/10.1177/2050313X211025104 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Treatment of facial reactive B-cell rich lymphoid proliferation with dapsone.
J Dermatol
January 2025
Department of Dermatology, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan.
Reactive B-cell rich lymphoid proliferation (rB-LP), once called pseudolymphoma, is a benign lymphoproliferative disorder, which is histologically characterized by dense dermal infiltrate forming reactive germinal centers with tingible body macrophages. The disease frequently involves the face, scalp, and ear lobes. Treatment includes topical or intralesional steroids, surgical resection, ultraviolet therapy, laser treatment, and radiation therapy.
View Article and Find Full Text PDFCutaneous pseudolymphoma successfully treated with intralesional triamcinolone acetonide: A case report.
SAGE Open Med Case Rep
January 2025
Division of Dermatology, Department of Medicine, McMaster University, Hamilton, ON, Canada.
Cutaneous pseudolymphoma refers to a group of skin conditions that simulate lymphoma either clinically and/or histologically. Cutaneous pseudolymphoma is a benign disorder that can often be misdiagnosed and has a wide range of treatment modalities. Currently, there is no gold standard of treatment, and the literature would benefit from more reports on successful and unsuccessful treatments of cutaneous pseudolymphoma.
View Article and Find Full Text PDFClinical characteristics and serological profiles of Lyme disease in children: a 15-year retrospective cohort study in Switzerland.
Lancet Reg Health Eur
January 2025
Division of Infectious Diseases and Hospital Epidemiology, Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.
Background: Lyme disease (LD) is caused by and is the most common tickborne disease in the northern hemisphere. Although classical characteristics of LD are well-known, the diagnosis and treatment are often delayed. Laboratory diagnosis by serological testing is recommended for most LD manifestations.
View Article and Find Full Text PDFCase report of disseminated borrelial lymphocytoma with isolation of sensu stricto in chronic lymphatic leukemia stage Binet A-an 11 year follow up.
Front Med (Lausanne)
October 2024
National Reference Center for Borrelia, Bavarian Health and Food Safety Authority, Oberschleissheim, Germany.
Article Synopsis
- The case report describes a patient with chronic lymphocytic B cell leukemia (B-CLL) who developed skin lesions that were initially misdiagnosed as leukemia cutis but were later identified as cutaneous borreliosis (specifically lymphocytoma).
- Borrelia bacteria were successfully isolated from the patient’s skin lesions, and antibiotic treatment resulted in significant improvement, although a second course of antibiotics was necessary for full resolution.
- After 11 years of follow-up, the patient remained free of skin lesions and stable in her B-CLL condition without needing chemotherapy, highlighting the interplay between Lyme disease and pre-existing malignancies.
Article Synopsis
- Cutaneous reactive lymphoid proliferation (CRLP) mimics cutaneous lymphoma, making it essential to differentiate between the two for correct diagnosis and treatment.* -
- CRLP can be caused by factors like viruses, drugs, or skin trauma, and requires careful evaluation of clinical and histopathological features for accurate diagnosis.* -
- A case study highlighted CRLP linked to antidepressant and antihypertensive medications, where excision confirmed the diagnosis, showing benign characteristics with no clonality and prompting ongoing monitoring for recurrence.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!